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Editorial
The Journal of Endometriosis (JE) was created almost a year ago and was successfully launched in Glasgow at the 56th Annual Meeting of the Society for Gynecologic Investigation (SGI).
One of the fundamental principles upon which the JE was founded was the need to create a unified medical and scientific, peer-reviewed voice for endometriosis research such that the disease and its numerous, systemic manifestations in women of all ages could be recognized. Until the publication of the JE, research on endometriosis had to be published in journals with quite a different orientation (fertility, surgery, reproductive medicine). For the first time ever, all important research related to endometriosis has a pertinent destination.
The second reason for its creation is that the journal can rely on an Editorial Board and a network of reviewers who are highly competent and well-regarded in their areas of interest: they are all qualified scientists and clinicians committed to the fundamental concepts of the JE. I sincerely thank all of them for contributing to the conception and development of this journal, the only one in the world totally dedicated to endometriosis and its treatments. Without them and without their high-quality contributions, the JE would never be able to appear in print.
With an effective electronic counterpart that enables even faster dissemination of scientific information and a group of scientists entirely committed to the continuous improvement of the journal, the JE aims at becoming an authoritative point of reference for clinicians and researchers in the field of endometriosis. It also aims to provide a forum for sharing the latest medical and surgical solutions, the most recent non-invasive diagnostic tools, and the best therapeutic choices.
The first 2010 issue sets some milestones for the Journal of Endometriosis. First of all, with this issue the JE is applying to the Literature Selection Technical Review Committee (LSTRC) of the National Library of Medicine for indexing in PubMed. A PubMed search on "Endometrio-sis" reveals results that are surprisingly disappointing: despite the roughly 90 million women and girls who are suffering from endometriosis worldwide, there are no journals dealing with endometriosis to be found in the journals database. Having the Journal of Endometriosis listed in PubMed, thereby increasing awareness of endometriosis among various physician specialties, government entities and universities, would therefore be extremely relevant for the international scientific community.
We trust the LSTRC will consider the "quality" of the journal (scientific merit, editorial work and production) as well as its "importance" (especially for educators, administrators, health professionals, students, and policymakers) to be high enough to have the JE accepted into PubMed. To this end, we have been encouraging quality articles with a high impact on education.
Besides being indexed in PubMed, the other major ambition is to obtain an Impact Factor, the measure reflecting the average number of citations of articles published in scientific journals, one that is too often used as a proxy for evaluating the importance of a journal in its field. These two achievements are correlated, since once a journal is listed in PubMed all its contents are available on the PubMed homepage in the form of abstracts. Any scientist searching for articles dealing with a specific topic can access them and, hopefully, cite the source in his or her work: the higher the number of citations to a specific journal, the higher its first impact factor. Secondly, besides publishing peer-reviewed, original clinical and laboratory investigations, reviews, editorials, letters and a restricted number of case reports, the JE will encourage the publication of abstracts presented at international scientific meetings. We will also invite world-famous speakers who have given lectures at relevant international scientific events to write review articles dealing with critical and innovative topics related to endometriosis.
Thirdly, the JE will start publishing peer-reviewed Supplements to the main volume, and special issues containing 2010 roadmap for the Journal of Endometriosis I would truly like to see all members of the Editorial Board as well as investigators who are specialized in the treatment of endometriosis actively involved in the editorial activities of the JE, with the aim of promoting innovation and providing different perspectives. Innovation, and even controversy, are necessary to bring progress and development to the disputed field of endometriosis.
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Editor-in-Chief Journal of Endometriosis indexable articles, so as to provide readers with a balanced, up-to-date overview of a relevant subject in the field of endometriosis. High-quality supplements constitute an important body of education and usually contribute to enhancing the circulation of the journal.
The accomplishments of 2009 are quite gratifying, but much hard work remains to be done. I trust all members of the Editorial Board and reviewers will continue collaborating with the JE not only through the quick revision of papers, but also through the submission of quality articles.
